Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients;Mısır'lı Budd-Chiari sendromlu hastalarda Faktör G1691A Leiden major bir etyolojik faktördür

Turkish Journal of Hematology

Volumn 28, Issue 4, 2011, Pages 299-305

  Abdel Ghaffar, Tawhida Y ^a,b   Elsayed, Solaf M ^a,b,c   Sakr, Mohamed A ^d   Elsobky, Ezzat S ^b,c   Abdelhakam, Sara M ^d   Yousuf, Said ^c   Eǧin, Yonca ^e   Akar, Nejat ^e  

^a Yassin Abdelghaffar Charity Center for Liver Disease and Research   (Egypt)

^b Ain Shams University   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d AIN SHAMS UNIVERSITY   (Egypt)

^e ANKARA UNIVERSITY   (Turkey)

Author keywords

Behcet's syndrome; Budd Chiari syndrome; Factor V Leiden; Gaucher; Methylenetetrahydrofolate; Niemann pick; Prothrombin; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTHROMBIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ASCITES; BEHCET DISEASE; BUDD CHIARI SYNDROME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE; GENE MUTATION; GENOTYPE; HUMAN; INFERIOR CAVA VEIN; LIPIDOSIS; LIVER VEIN THROMBOSIS; MALE; MYELOPROLIFERATIVE DISORDER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 82955222846     PISSN: 13007777     EISSN: 13085263     Source Type: Journal    
DOI: 10.5152/tjh.2011.84     Document Type: Article

References (23)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC, European Group for the Study of Vascular Disorders of the Liver. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-71. [CrossRef]
2. Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, Sood GK, Mitra SK, Khanna SK, Walia BS. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994;73:21-36. [CrossRef]
3. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-8.
4. Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, Erlinger S, Valla DC. Factor V Leiden related Budd-Chiari syndrome. Gut 2001;48:264-8. [CrossRef]
5. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001;34:666-70. [CrossRef]
6. Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, Okudaira M, Ohbu M, Okuda K. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995;22:1-9. [CrossRef]
7. Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol 2008;14:2858-62. [CrossRef]
8. Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int 2009;29:253-9. [CrossRef]
9. Mahmoud AEA, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997;40:798-800. [CrossRef]
10. Minnema MC, Janssen HL, Niermeijer P, de Man RA. Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J Hepatol 2000;33:509-12. [CrossRef]
11. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geoegraphic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
12. Li X-M, Wei YF, Hao HL, He LS, Li JD, Mei B, Wang SY, Wang C, Wang JX, Zhu JZ, Liang JQ. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol 2002;71:11-4. [CrossRef]
13. Daniel WW. Biostatistics: A foundation for analysis in the health sciences, 6th edition. John Wiley and sons, Inc., New York, 1995.
14. Dutta AK, Chacko A, George B, Joseph JA, Nair SC, Mathews V. Risk factors of thrombosis in abdominal veins. World J Gastroenterol 2008;28:4518-22. [CrossRef]
15. Ulu A, Elsobky E, Elsayed M, Yildiz Z, Tekin M, Akar N. Frequency of five thrombophilic polymorphisms in the Egyptian population. Turk J Hematol 2006;23:100-3.
16. El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Ann Hematol 2004;83:712-5. [CrossRef]
17. Haliloglu M, Hoffer FA, Haight AE, Cunningham JM. Budd-Chiari syndrome caused by Gaucher's disease. Pediatr Radiol 1999;29:908-10. [CrossRef]
18. Ishii H, Takahashi T, Toyono M, Tamura M, Harada K, Yoshida M, Nishikawa Y, Enomoto K, Takada G. Acid sphingomyelinase deficiency: cardiac dysfunction and characteristic findings of the coronary arteries. J Inherit Metab Dis 2006;29:232-4. [CrossRef]
19. Lin GL, Xu PQ, Qi H, Lian JH, Zheng H, Dang XW. Relations of Budd-Chiari syndrome to prothrombin gene mutation. Hepatobiliary Pancreat Dis Int 2004;3:214-8.
20. Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell'Era A, Bucciarelli P, Mannucci PM. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006;44:1528-34. [CrossRef]
21. Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gäken J, Wendon J, Heaton ND, Mufti GJ. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006;130:2031-8. [CrossRef]
22. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol 1997;92:858-62.
23. Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL; EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151:167-75.